China Gaucher Disease Market Research Report 2018

February 2018 | 97 pages | ID: C75439289BCEN
QYResearch

Abstracts

The global Gaucher Disease market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Gaucher Disease development status and future trend in China, focuses on top players in China, also splits Gaucher Disease by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Sanofi
• Shire
• Actelion Pharma
• Pfizer
• ISU Pharm

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Enzyme Replacement Therapy
• Substrate Reduction Therapy

On the basis of the end users/application, this report covers

• Non-Neuronopathic Gaucher Disease
• Neuronopathic Gaucher Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Gaucher Disease Market Research Report 2017

1 GAUCHER DISEASE OVERVIEW

1.1 Product Overview and Scope of Gaucher Disease
1.2 Classification of Gaucher Disease by Product Category
  1.2.1 China Gaucher Disease Sales (K Units) Comparison by Type (2012-2022)
  1.2.2 China Gaucher Disease Sales (K Units) Market Share by Type in 2016
  1.2.3 Enzyme Replacement Therapy
  1.2.4 Substrate Reduction Therapy
1.3 China Gaucher Disease Market by Application/End Users
  1.3.1 China Gaucher Disease Sales (K Units) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Non-Neuronopathic Gaucher Disease
  1.3.3 Neuronopathic Gaucher Disease
1.4 China Gaucher Disease Market by Region
  1.4.1 China Gaucher Disease Market Size (Million USD) Comparison by Region (2012-2022)
  1.4.2 South China Gaucher Disease Status and Prospect (2012-2022)
  1.4.3 East China Gaucher Disease Status and Prospect (2012-2022)
  1.4.4 Southwest China Gaucher Disease Status and Prospect (2012-2022)
  1.4.5 Northeast China Gaucher Disease Status and Prospect (2012-2022)
  1.4.6 North China Gaucher Disease Status and Prospect (2012-2022)
  1.4.7 Central China Gaucher Disease Status and Prospect (2012-2022)
1.5 China Market Size (Sales and Revenue) of Gaucher Disease (2012-2022)
  1.5.1 China Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2022)
  1.5.2 China Gaucher Disease Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 CHINA GAUCHER DISEASE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Gaucher Disease Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Gaucher Disease Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Gaucher Disease Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 China Gaucher Disease Market Competitive Situation and Trends
  2.4.1 China Gaucher Disease Market Concentration Rate
  2.4.2 China Gaucher Disease Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Gaucher Disease Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA GAUCHER DISEASE SALES AND REVENUE BY REGION (2012-2017)

3.1 China Gaucher Disease Sales (K Units) and Market Share by Region (2012-2017)
3.2 China Gaucher Disease Revenue (Million USD) and Market Share by Region (2012-2017)
3.3 China Gaucher Disease Price (USD/Unit) by Regions (2012-2017)

4 CHINA GAUCHER DISEASE SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 China Gaucher Disease Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 China Gaucher Disease Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 China Gaucher Disease Price (USD/Unit) by Type (2012-2017)
4.4 China Gaucher Disease Sales Growth Rate (%) by Type (2012-2017)

5 CHINA GAUCHER DISEASE SALES BY APPLICATION (2012-2017)

5.1 China Gaucher Disease Sales (K Units) and Market Share by Application (2012-2017)
5.2 China Gaucher Disease Sales Growth Rate (%) by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 CHINA GAUCHER DISEASE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gaucher Disease Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Shire
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Gaucher Disease Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Shire Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Actelion Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Gaucher Disease Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Actelion Pharma Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Gaucher Disease Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ISU Pharm
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Gaucher Disease Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ISU Pharm Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview

7 GAUCHER DISEASE MANUFACTURING COST ANALYSIS

7.1 Gaucher Disease Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gaucher Disease

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gaucher Disease Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gaucher Disease Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA GAUCHER DISEASE MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 China Gaucher Disease Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 China Gaucher Disease Sales (K Units) Forecast by Type (2017-2022)
11.3 China Gaucher Disease Sales (K Units) Forecast by Application (2017-2022)
11.4 China Gaucher Disease Sales (K Units) Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2012-2022)
Table Gaucher Disease Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Gaucher Disease Sales (K Units) by Application (2016-2022)
Figure Product Picture of Gaucher Disease
Table China Gaucher Disease Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
Figure China Gaucher Disease Sales Volume Market Share by Types in 2016
Figure Enzyme Replacement Therapy Product Picture
Figure Substrate Reduction Therapy Product Picture
Figure China Gaucher Disease Sales (K Units) Comparison by Application (2012-2022)
Figure China Sales Market Share (%) of Gaucher Disease by Application in 2016
Figure Non-Neuronopathic Gaucher Disease Examples
Table Key Downstream Customer in Non-Neuronopathic Gaucher Disease
Figure Neuronopathic Gaucher Disease Examples
Table Key Downstream Customer in Neuronopathic Gaucher Disease
Figure South China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure East China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure North China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central China Gaucher Disease Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2022)
Figure China Gaucher Disease Revenue (Million USD) and Growth Rate (%)(2012-2022)
Table China Gaucher Disease Sales of Key Players/Manufacturers (2012-2017)
Table China Gaucher Disease Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gaucher Disease Sales Share (%) by Players/Manufacturers
Figure 2017 China Gaucher Disease Sales Share (%) by Players/Manufacturers
Table China Gaucher Disease Revenue by Players/Manufacturers (2012-2017)
Table China Gaucher Disease Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Gaucher Disease Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Gaucher Disease Revenue Market Share (%) by Players/Manufacturers
Table China Market Gaucher Disease Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Gaucher Disease Average Price of Key Players/Manufacturers in 2016
Figure China Gaucher Disease Market Share of Top 3 Players/Manufacturers
Figure China Gaucher Disease Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Gaucher Disease Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Gaucher Disease Product Category
Table China Gaucher Disease Sales (K Units) by Regions (2012-2017)
Table China Gaucher Disease Sales Share (%) by Regions (2012-2017)
Figure China Gaucher Disease Sales Share (%) by Regions (2012-2017)
Figure China Gaucher Disease Sales Market Share (%) by Regions in 2016
Table China Gaucher Disease Revenue (Million USD) and Market Share by Regions (2012-2017)
Table China Gaucher Disease Revenue Market Share (%) by Regions (2012-2017)
Figure China Gaucher Disease Revenue Market Share (%) by Regions (2012-2017)
Figure China Gaucher Disease Revenue Market Share (%) by Regions in 2016
Table China Gaucher Disease Price (USD/Unit) by Regions (2012-2017)
Table China Gaucher Disease Sales (K Units) by Type (2012-2017)
Table China Gaucher Disease Sales Share (%) by Type (2012-2017)
Figure China Gaucher Disease Sales Share (%) by Type (2012-2017)
Figure China Gaucher Disease Sales Market Share (%) by Type in 2016
Table China Gaucher Disease Revenue (Million USD) and Market Share by Type (2012-2017)
Table China Gaucher Disease Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Gaucher Disease by Type (2012-2017)
Figure Revenue Market Share of Gaucher Disease by Type in 2016
Table China Gaucher Disease Price (USD/Unit) by Types (2012-2017)
Figure China Gaucher Disease Sales Growth Rate (%) by Type (2012-2017)
Table China Gaucher Disease Sales (K Units) by Applications (2012-2017)
Table China Gaucher Disease Sales Market Share (%) by Applications (2012-2017)
Figure China Gaucher Disease Sales Market Share (%) by Application (2012-2017)
Figure China Gaucher Disease Sales Market Share (%) by Application in 2016
Table China Gaucher Disease Sales Growth Rate (%) by Application (2012-2017)
Figure China Gaucher Disease Sales Growth Rate (%) by Application (2012-2017)
Table Sanofi Gaucher Disease Basic Information List
Table Sanofi Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Sanofi Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Sanofi Gaucher Disease Sales Market Share (%) in China (2012-2017)
Figure Sanofi Gaucher Disease Revenue Market Share (%) in China (2012-2017)
Table Shire Gaucher Disease Basic Information List
Table Shire Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Shire Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Shire Gaucher Disease Sales Market Share (%) in China (2012-2017)
Figure Shire Gaucher Disease Revenue Market Share (%) in China (2012-2017)
Table Actelion Pharma Gaucher Disease Basic Information List
Table Actelion Pharma Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Actelion Pharma Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Actelion Pharma Gaucher Disease Sales Market Share (%) in China (2012-2017)
Figure Actelion Pharma Gaucher Disease Revenue Market Share (%) in China (2012-2017)
Table Pfizer Gaucher Disease Basic Information List
Table Pfizer Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure Pfizer Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2017)
Figure Pfizer Gaucher Disease Sales Market Share (%) in China (2012-2017)
Figure Pfizer Gaucher Disease Revenue Market Share (%) in China (2012-2017)
Table ISU Pharm Gaucher Disease Basic Information List
Table ISU Pharm Gaucher Disease Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
Figure ISU Pharm Gaucher Disease Sales (K Units) and Growth Rate (%)(2012-2017)
Figure ISU Pharm Gaucher Disease Sales Market Share (%) in China (2012-2017)
Figure ISU Pharm Gaucher Disease Revenue Market Share (%) in China (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gaucher Disease
Figure Manufacturing Process Analysis of Gaucher Disease
Figure Gaucher Disease Industrial Chain Analysis
Table Raw Materials Sources of Gaucher Disease Major Players/Manufacturers in 2016
Table Major Buyers of Gaucher Disease
Table Distributors/Traders List
Figure China Gaucher Disease Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure China Gaucher Disease Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gaucher Disease Price (USD/Unit) Trend Forecast (2017-2022)
Table China Gaucher Disease Sales (K Units) Forecast by Type (2017-2022)
Figure China Gaucher Disease Sales (K Units) Forecast by Type (2017-2022)
Figure China Gaucher Disease Sales Volume Market Share Forecast by Type in 2022
Table China Gaucher Disease Sales (K Units) Forecast by Application (2017-2022)
Figure China Gaucher Disease Sales Volume Market Share Forecast by Application (2017-2022)
Figure China Gaucher Disease Sales Volume Market Share Forecast by Application in 2022
Table China Gaucher Disease Sales (K Units) Forecast by Regions (2017-2022)
Table China Gaucher Disease Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gaucher Disease Sales Volume Share Forecast by Regions (2017-2022)
Figure China Gaucher Disease Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources